Kora Saúde Participações S.A. (BVMF:KRSA3)

Kora Saúde Participações Income Statement

Financials in millions BRL. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,268	2,260	2,047	1,262	612.29
Revenue Growth (YoY)	0.38%	10.41%	62.20%	106.09%	38.52%
Cost of Revenue	1,814	1,785	1,559	939.16	455.56
Gross Profit	454.28	474.25	487.95	322.7	156.72
Selling, General & Admin	188.67	192.81	224.67	175.48	82.59
Other Operating Expenses	0.43	-3.56	-5.09	21.02	-5.1
Operating Expenses	189.1	189.25	219.59	196.5	77.5
Operating Income	265.18	285	268.36	126.2	79.23
Interest Expense	-358.18	-345.8	-302.42	-106.47	-52.33
Interest & Investment Income	18.6	27.06	57.84	14.62	5.52
Earnings From Equity Investments	1.9	3.92	2.62	0.84	-0.1
Currency Exchange Gain (Loss)	-	-	-	0.08	-
Other Non Operating Income (Expenses)	-92.82	-34.97	-49.16	-10.19	-
EBT Excluding Unusual Items	-165.32	-64.79	-22.76	25.08	32.32
Legal Settlements	-0.48	0.02	-0.47	5.77	-
Other Unusual Items	-8.12	-69.21	-66.49	-28.02	-
Pretax Income	-173.92	-133.99	-89.72	2.83	32.32
Income Tax Expense	-5.46	24.08	4.75	57.79	14.78
Earnings From Continuing Operations	-168.45	-158.07	-94.47	-54.96	17.54
Minority Interest in Earnings	-8.82	-9.56	-13.12	-8.76	-1.67
Net Income	-177.28	-167.62	-107.59	-63.72	15.87
Net Income to Common	-177.28	-167.62	-107.59	-63.72	15.87
Shares Outstanding (Basic)	77	77	77	58	40
Shares Outstanding (Diluted)	77	77	77	58	40
Shares Change (YoY)	0.03%	0.32%	33.80%	43.75%	60.96%
EPS (Basic)	-2.29	-2.17	-1.40	-1.11	0.40
EPS (Diluted)	-2.29	-2.17	-1.40	-1.11	0.40
Free Cash Flow	-162.63	-325.44	149	-83.72	-13.45
Free Cash Flow Per Share	-2.10	-4.21	1.93	-1.45	-0.34
Gross Margin	20.03%	20.99%	23.84%	25.57%	25.60%
Operating Margin	11.69%	12.61%	13.11%	10.00%	12.94%
Profit Margin	-7.82%	-7.42%	-5.26%	-5.05%	2.59%
Free Cash Flow Margin	-7.17%	-14.40%	7.28%	-6.64%	-2.20%
EBITDA	399.09	434.02	376.62	187.13	107.22
EBITDA Margin	17.59%	19.21%	18.40%	14.83%	17.51%
D&A For EBITDA	133.91	149.02	108.26	60.92	27.99
EBIT	265.18	285	268.36	126.2	79.23
EBIT Margin	11.69%	12.61%	13.11%	10.00%	12.94%
Effective Tax Rate	-	-	-	2039.13%	45.73%

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.